4.5 Article

Ultrafast PCR Detection of COVID-19 by Using a Microfluidic Chip-Based System

Journal

BIOENGINEERING-BASEL
Volume 9, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/bioengineering9100548

Keywords

microchip-based system; polymerase chain reaction; microfluidics; COVID-19; point-of-care test

Funding

  1. Key Technology Project of Shenzhen Science and Technology Innovation Commission [202011023000417]
  2. Project of Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone [HZQB-KCZYB-2020083]

Ask authors/readers for more resources

A microchip-based ultrafast PCR system called SWM-02 has been proposed as a rapid, portable, and low-cost strategy for molecular diagnosis. It can complete an ultrafast COVID-19 RT-PCR test within 40 minutes and has excellent performance and good linear correlation.
With the evolution of the pandemic caused by the Coronavirus disease of 2019 (COVID-19), reverse transcriptase-polymerase chain reactions (RT-PCR) have invariably been a golden standard in clinical diagnosis. Nevertheless, the traditional polymerase chain reaction (PCR) is not feasible for field application due to its drawbacks, such as time-consuming and laboratory-based dependence. To overcome these challenges, a microchip-based ultrafast PCR system called SWM-02 was proposed to make PCR assay in a rapid, portable, and low-cost strategy. This novel platform can perform 6-sample detection per run using multiple fluorescent channels and complete an ultrafast COVID-19 RT-PCR test within 40 min. Here, we evaluated the performance of the microdevice using the gradient-diluted COVID-19 reference samples and commercial PCR kit and determined its limit-of-detection (LoD) as 500 copies/mL, whose variation coefficients for the nucleocapsid (N) gene and open reading frame 1 ab region (ORF1ab) gene are 1.427% and 0.7872%, respectively. The system also revealed an excellent linear correlation between cycle threshold (Ct) values and dilution factors (R-2 > 0.99). Additionally, we successfully detected the target RNAs and internal gene in the clinical samples by fast PCR, which shows strong consistency with conventional PCR protocol. Hence, with compact dimension, user-friendly design, and fast processing time, SWM-02 has the capability of offering timely and sensitive on-site molecular diagnosis for prevention and control of pathogen transmission.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available